Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate if it is safe to use tissue plasminogen activator
(tPA) within 6 hours of stroke onset when combined with hypothermia.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, San Diego
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)